ASX Highlights: AML3D And 2 Other Promising Penny Stocks

The Australian market has been navigating a complex landscape, with the ASX 200 showing resilience despite pressures from rising oil prices and geopolitical tensions. In such an environment, investors often seek opportunities that balance risk with potential reward. Penny stocks, though sometimes seen as relics of past market eras, continue to offer intriguing possibilities for those willing to explore smaller or newer companies that demonstrate strong financial health. This article will highlight several penny stocks on the ASX that stand out for their financial strength and growth potential amidst current market conditions.

Let's dive into some prime choices out of the screener.

AML3D (ASX:AL3)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: AML3D Limited designs, manufactures, and sells industrial-scale metal 3D printing systems and provides contract manufacturing services to various sectors including aerospace, marine, defence, oil and gas, mining, and general manufacturing in Australia, the UK, and the US with a market cap of A$87.95 million.

Operations: The company generates revenue of A$12.47 million from its 3D printing services and machinery sales.

Market Cap: A$87.95M

AML3D Limited, with a market cap of A$87.95 million, has shown revenue growth to A$11.76 million for the year ending June 30, 2026, up from A$6.67 million the previous year. Despite being unprofitable with a net loss of A$4.48 million, its short-term assets significantly exceed liabilities and it remains debt-free. The company has a stable cash runway exceeding three years without shareholder dilution in the past year. However, its share price is highly volatile and weekly volatility remains higher than most Australian stocks despite stability over the past year. Earnings are forecast to grow substantially annually by consensus estimates.

• Navigate through the intricacies of AML3D with our comprehensive balance sheet health report here.
• Gain insights into AML3D's outlook and expected performance with our report on the company's earnings estimates.

Metal Powder Works (ASX:MPW)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Metal Powder Works Limited specializes in producing metal powders for additive manufacturing and other advanced applications, with a market cap of A$282.26 million.

Operations: The company's revenue segment is derived entirely from its Metal Powders division, generating A$1.65 million.

Market Cap: A$282.26M

Metal Powder Works Limited, with a market cap of A$282.26 million, reported revenues of A$1.65 million for the year ending June 30, 2026, indicating it is pre-revenue. The company remains unprofitable with increasing losses and has recently focused solely on its metal powder business by discontinuing its legacy K-TIG welding operations, resulting in a non-cash impairment charge of approximately A$1.31 million. Despite significant insider selling and an inexperienced management team, the company maintains sufficient short-term assets to cover liabilities and is debt-free with a stable cash runway exceeding one year.

• Click here to discover the nuances of Metal Powder Works with our detailed analytical financial health report.
• Examine Metal Powder Works' earnings growth report to understand how analysts expect it to perform.

MyState (ASX:MYS)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: MyState Limited operates in Australia offering banking, trustee, equipment finance, and managed fund products and services with a market cap of A$836.76 million.

Operations: The company's revenue is primarily derived from My State Financial Limited (MSF) Group at A$235.37 million, followed by Wealth Management contributing A$16.44 million, and Corporate and Consolidation adding A$0.06 million.

Market Cap: A$836.76M

MyState Limited, with a market cap of A$836.76 million, demonstrates stable weekly volatility and an appropriate loans-to-deposits ratio of 124%. The company's net profit margins improved to 22.3%, supported by high-quality earnings and a robust growth in profits over the past year at 58%, outpacing the industry average. MyState's management team is seasoned, with an experienced board averaging eight years in tenure. Despite having a very high assets-to-equity ratio of 21.3x, MyState maintains primarily low-risk funding sources and is actively seeking acquisitions to enhance value further, as stated by its CEO Brett Alexander Morgan.

• Click to explore a detailed breakdown of our findings in MyState's financial health report.
• Gain insights into MyState's future direction by reviewing our growth report.

Where To Now?

• Explore the 396 names from our ASX Penny Stocks screener here.
• Seeking Other Investments? We've found 7 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com